Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-036905
Filing Date
2025-04-21
Accepted
2025-04-21 17:09:00
Documents
1
Period of Report
2025-04-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2512604-7_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2512604-7_4seq1.xml 4 5384
  Complete submission text file 0001104659-25-036905.txt   6822
Mailing Address C/O NYSE EURONEXT 11 WALL STREET NEW YORK NY 10005
Business Address
LEIBOWITZ LAWRENCE E (Reporting) CIK: 0001276505 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40949 | Film No.: 25854267

Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Issuer) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 7372 Services-Prepackaged Software
(CF Office: 06 Technology)